This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on Cholangiocarcinoma (CCA), cancers that arise from biliary epithelium including intrahepatic cholangio (ICC), and gallbladder cancer (GB CA).
Nanomedical Drug Delivery for Neurodegenerative Diseases, 2022, Pages 17-39
This book chapter advances SDG #3 and #10 by presenting drug delivery systems based on nanotechnology to treat Alzheimer’s disease.
Nanomedical Drug Delivery for Neurodegenerative Diseases, 2022, Pages 223-242
This book chapter advances SDG #3 and #10 by highlighting a few newly updated nano drug delivery technologies implemented in Alzheimer’s disease therapies and prospects for the future regarding potential molecular mechanisms of nano drug delivery methods
Elsevier,
Treatment of Skin Disease (Fifth Edition)
Comprehensive Therapeutic Strategies
2018, Pages 579-581
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing insight into palmoplantar keratoderma, a heterogeneous group of disorders characterized by thickening of the palms and soles.
Elsevier,
Treatment of Skin Disease (Fifth Edition)
Comprehensive Therapeutic Strategies
2018, Pages 621-623
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing content on Peutz–Jeghers syndrome (PJS), a rare hereditary disorder of polyposis.
Elsevier,
Treatment of Skin Disease (Fifth Edition)
Comprehensive Therapeutic Strategies
2018, Pages 764-768
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on scleroderma, a rare multisystem disease characterized by skin fibrosis, autoantibody production, and vascular abnormalities often leading to visceral disease.
Elsevier,
Epigenetics of Stress and Stress Disorders, Volume 31 in Translational Epigenetics, 2022, Pages 137-162
Reviews the literature on the epigenetics of PTSD and interpret findings through the lens of understanding the implications for adverse physical health outcomes. The goal of SDG target is to cover treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders.
The relationship between healthy lifestyles and wellbeing, especially focused on women and pregnancy, continues to grow to understand and determine factors connected to chronic disease and to decrease them. Supports SDG target: 3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births
This book chapter advances SDG 3 and 10 by presenting that (1) some of these depression scales do not correlate, suggesting that they assess different aspects of depression; (2) reports of depression in dementia vary based on depression in dementia scale used; and (3) severe memory impairment may impact the ability to assess depression in the patients using self-reports.
This book chapter advances SDG #3 and #10 by reviewing studies that showed treatments with multiple sessions of rTMS can influence cognition in people with neurodegenerative diseases. The chapter also considers novel therapeutic approaches based on the clinical use of rTMS.
